M Holdings Securities, Inc. - MYMD PHARMACEUTICALS INC ownership

MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 49 filers reported holding MYMD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
M Holdings Securities, Inc. ownership history of MYMD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$106
-13.1%
70,9090.0%0.02%
+69.2%
Q1 2023$122
+48.8%
70,9090.0%0.01%
+44.4%
Q4 2022$82
-100.0%
70,9090.0%0.01%
-55.0%
Q3 2022$185,000
+20.1%
70,9090.0%0.02%
+25.0%
Q2 2022$154,000
-53.3%
70,9090.0%0.02%
-36.0%
Q1 2022$330,000
-26.2%
70,9090.0%0.02%
-43.2%
Q2 2021$447,00070,9090.04%
Other shareholders
MYMD PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Shay Capital LLC 309,178$671,0000.14%
Taylor & Morgan Wealth Management, LLC 17,086$37,0000.04%
Ikarian Capital, LLC 81,089$176,0000.03%
Corundum Group, Inc. 19,600$43,0000.03%
M Holdings Securities, Inc. 70,909$154,0000.02%
Praetorian Wealth Management, Inc. 15,000$32,0000.01%
Western Wealth Management, LLC 27,050$115,0000.01%
Mirae Asset Global Investments Co., Ltd. 1,073,765$2,330,0000.01%
Virtu Financial LLC 16,063$35,0000.00%
SeaCrest Wealth Management, LLC 6,800$15,0000.00%
View complete list of MYMD PHARMACEUTICALS INC shareholders